Eligibility Module

Eligibility Module

The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.

Eligibility Module path is as follows:

Study -> Protocol Section -> Eligibility Module

Eligibility Module


Ignite Creation Date: 2025-12-25 @ 3:10 AM
Ignite Modification Date: 2025-12-25 @ 3:10 AM
NCT ID: NCT01098305
Eligibility Criteria: Inclusion Criteria: * males and females * over age 18 * used smokeless tobacco every day for the past year (confirmed with urinary cotinine) * residing within 100km of New Dehli for the next 4 months * interested in quitting use of smokeless tobacco. Exclusion Criteria: * currently enrolled or plan to enroll in another tobacco cessation program in the next 4 months * plan to use other smoking cessation treatments in the next 4 months * smoke cigarettes * have current substance abuse (e.g., opioids, cocaine, marijuana) verified by urine drug screen * have current (last 6-months) alcohol consumption that exceeds 25 standard drinks/week (if past abuse, must be symptom free for ≥ the past 12 months) * Current use or discontinuation within last 14 days of: 1. smoking cessation medications (bupropion, Varenicline, NRT); 2. antipsychotics, atypicals, mood-stabilizers, anti-depressants (tricyclics, SSRIs, MAOIs), anti-panic agents, anti-obsessive agents, anti-anxiety agents, stimulants; 3. Anti-coagulants; 4. Daily medication for asthma or diabetes (eligible with physician approval); * are pregnant, planning a pregnancy, or lactating * have a history or current diagnosis of psychosis, general anxiety disorder,bipolar disorder, or schizophrenia * have a current diagnosis of depression (if past diagnosis, must be symptom free for ≥ the past 12 months) * have an allergy to Varenicline * ever contemplated or attempted suicide * have serious/unstable disease within the past 6 months (e.g., cancer \[but melanoma\], heart disease, HIV/AIDS) * have a history of epilepsy or seizure disorder * have a history or diagnosis within the last 6 months of abnormal rhythms and/or tachycardia (\>100 beats/minute) * have a history or current diagnosis of COPD; cardiovascular disease (stroke, angina); heart attack in the last 6 months; and/or uncontrolled hypertension (SBP\>150 or DBP\>90)16) * have a history of kidney or liver failure * have any medical condition or medication that could compromise safety as determined by a study physician * cannot provide informed consent or complete the study tasks as determined by the Principal Investigator or study physician.
Healthy Volunteers: True
Sex: ALL
Minimum Age: 18 Years
Study: NCT01098305
Study Brief:
Protocol Section: NCT01098305